Demonstration of Quality, Safety and Efficacy of Biological Products Subject to Changes in Their Manufacturing Process
Ensuring quality, safety and efficacy of the medicinal products placed on the market of the Russian Federation constitutes the area that requires strict regulation. When changes are made to the manufacturing process, the manufacturer generally needs to evaluate the relevant quality attributes of the...
Saved in:
| Main Authors: | A. N. Asiliev, E. V. Gavrishina, R. R. Niyazov, A. A. Snegireva, V. K. Adonin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosimilars: development and investigation using achievements in modern biotechnology
by: R. R. Niyazov, et al.
Published: (2021-02-01) -
Results of the Estimation of Biosimilarity of RinLiz<sup>®</sup> (LLC «GEROPHARM», Russia) and Humalog<sup>®</sup> (Lilly France, France) Using the Method of the Hyperinsulinemic Eulygemic Clamp on Healthy Voluntary
by: A. Yu. Mayorov, et al.
Published: (2020-05-01) -
Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52
by: Steven R. Feldman, et al.
Published: (2024-12-01) -
Exosomes in clinical trial and their production in compliance with good manufacturing practice
by: Yu-Shuan Chen, et al.
Published: (2020-01-01) -
CASE STUDY ON THE DEMONSTRATION OF CAPABILITY TO MANUFACTURING PROCESS
by: Liviu Marius CIRTINA, et al.
Published: (2014-05-01)